Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
27750 was the number of prescriptions they reported in Q3 of last year, before then downgrading it in q4.
So Shield are now at the level we all thought they were six months ago. Really poor. Was looking to buy in if there were any green shoots but it's tough to see where they go from here?
Topped up 100,000 1.34P very happy, anyone buying today at under 2P should do well
Against Hardmans research of 65k, 28.8 is more than 50% of target. And a hell off a way of 45k, as a said before we need a complete step change in the company & we didn't get it.
Shocking....
£1.2 million for Europe, its time to cut ties & get a new partner. Look at the size of Germany, France, Spain, etc and all we can get us 1.2 million.
A shambles in Texas wiping out gains elsewhere.
A big boast about a 310% increase when in actual fact you missed your own revised down target by 40%.
Certainly not the greatest set of results but better than expected, and nothing to write home and tell your granny about & really nothing to be proud of.
Should do 80% today on that news
Sure, if you are short, maybe! Lol.
Fantastic result.
Q3 2023 - $8,500,000
Q4 2023 - $14,500,000
Q1 2024- $15,000,000
Q2 2024 -$16,500,000
Q3 2024 - $22,500,000
Q4 2024 - $31,500,000
Q1 2025 - $38,900,000
Looks ok to me :)
Q2 2025+
$45,700,000
HarChris: Like you, I see nothing in this update to justify the optimism shown by a couple of the other posters.
It is, however, consistent with how this operation rolls though.
Still very much on track to end up how I suggested this one is likely to.
Did I miss the part about what action they have taken against that third party, who they previously blamed for those false prescription numbers? Or has it all been forgiven and forgotten? Lol.
A zombie outfit, to all intents and purposes in my sincere opinion - but this is AIM, so who knows, the SP might have a spike.
This is a terrible update, not sure where the positives are. A 1% quarterly increase in prescriptions, based on a disappointing Q4 2023 too, is terrible. This needs to be growing c50% minimum. We were meant to be at 50k per quarter 6 months ago. Still miles off.
CEO is clearly clueless, and has an excuse for everything.
$10m of cash will clearly not last the year
Yes but they have got backers to handle it, which normal for a healthy growing company!
EV includes debt, Shield only have cash because they keep taking on more debt. The EV isn't increasing.
How can market cap be same as cash , basically no value is being given for EV .
Compare the sales to previous year, huge increase in sales . Yet the price is down here .
You might just be being naive but Shield is 'not doing a lot better than many other Aim companies' , at this stage revenue is irrelevant, they were on a path to profitability and now they are MILES away - they are burning cash like nobody's business and have a mcap of £10m to raise against vs a £100m mcap last year.
The debt facility gives them another quarter to show some significant improvement but if nothing seen them it must surely be curtains.
Very happy to see the comments about the debt facility. They will get there in the end I think
It may not be as fast but there is growth and Shield is doing a lot better than many other AIM companies with only a speculative higher SP which have yet to make any income.
SP is a bargain imo.
The real increase is 1% on Q4 2023 - for a company supposedly targeting 330k prescriptions in 2024 28.8k is a rubbish number and provides conclusive proof that growth is no longer on track.
This is going to rocket up today!
''Need to see 45k scripts for 1st qtr 24 to get this back on track along with a reduction in monthly costs.
It will be tight.''
_______________
Traxpern, happy with 28800? Hardman research had 65k scripts at this stage.
There are 775M shares in issue so 3.5M is only 0.4% of the company, wouldn't require a TR1 unless someone was crossing a threshold at or above 3%.
I've decided to stay on the sidelines but tomorrow will indeed be interesting.
There were lots of massive block selling in last few months too but no TR1 was issued. Once it was 3.5M shares sold in one go but no TR1 or as such. This company has a history to not sharing important information with the market on time hence my comments about tomorrow. In this market you can't take anything for granted. Remember C4XD, TWD, AMTE etc? Better to be safe than sorry. GL anyway
I hope 100%. also there seems to be block buyer, wonder if we will see a TR1 rns soon...
Either it's gonna jump over 100% with solid positive outlook news or crash 50-60% with their typical dry rampy updates. Eitherway it's gonna be really interesting.
GLA
Great day
I hope they do. Looks like some shorts also closing so good luck to all the long suffering shareholders.